Regulation of Potassium Balance


Objectives

Upon completion of this chapter, the student should be able to answer the following questions:

  • How does the body maintain K + homeostasis?

  • What is the distribution of K + within the body compartments? Why is this distribution important?

  • What are the hormones and factors that regulate plasma K + levels? Why is this regulation important?

  • How do the various segments of the nephron transport K + , and how does the mechanism of K + transport by these segments determine how much K + is excreted in the urine?

  • Why are the distal tubule and collecting duct so important in regulating K + excretion?

  • How do plasma K + levels, aldosterone, vasopressin, tubular fluid flow rate, and acid-base balance influence K + excretion?

Key Terms

Hyperkalemia

Hypokalemia

Pseudohyperkalemia

Cardiac arrhythmias

Epinephrine

Insulin

Aldosterone

Tumor lysis syndrome

Rhabdomyolysis

ASDN

AVP

Chronic hypokalemia

Chronic hyperkalemia

Prostatin

ROMK

Glucocorticoids

K + homeostasis

Potassium (K + ) is one of the most abundant cations in the body and is critical for many cell functions, including cell volume regulation, intracellular pH regulation, DNA and protein synthesis, growth, enzyme function, resting membrane potential, and cardiac and neuromuscular activity. Despite wide fluctuations in dietary K + intake, [K + ] in cells and extracellular fluid (ECF) remains remarkably constant. Two sets of regulatory mechanisms safeguard K + homeostasis. First, several mechanisms regulate the [K + ] in the ECF. Second, other mechanisms maintain the amount of K + in the body constant by adjusting renal K + excretion to match dietary K + intake. It is the kidneys that regulate K + excretion.

Overview of K + Homeostasis

Total body K + is 50 mEq/kg of body weight, or 3500 mEq for a person weighing 70 kg. A total of 98% of the K + in the body is located within cells, where its average [K + ] is 150 mEq/L. A high intracellular [K + ] is required for many cell functions, including cell growth and division and volume regulation. Only 2% of total body K + is in the ECF, where its normal concentration is approximately 4 mEq/L. [K + ] in the ECF that exceeds ∼5.0 mEq/L constitutes hyperkalemia . Conversely, [K + ] in the ECF of less than ∼3.5 mEq/L constitutes hypokalemia .

In the Clinic

Hypokalemia is one of the most common electrolyte disorders in clinical practice and can be observed in as many as 20% of hospitalized patients. The most common causes of hypokalemia include administration of diuretic drugs (see Chapter 10 ), surreptitious vomiting (i.e., bulimia), and severe diarrhea. Gitelman syndrome (a genetic defect in the Na + -Cl symporter in the apical membrane of distal tubule cells) also causes hypokalemia (see Chapter 4 , Table 4.3 ). Hyperkalemia also is a common electrolyte disorder and is seen in 1%–10% of hospitalized patients. Hyperkalemia often is seen in patients with renal failure, in persons taking drugs such as angiotensin-converting enzyme inhibitors and K + -sparing diuretics (see Chapter 10 ), in persons with hyperglycemia (i.e., high blood sugar), and in the elderly. Pseudohyperkalemia , a falsely high plasma [K + ], is caused by traumatic lysis of red blood cells while blood is being drawn. Red blood cells, like all cells, contain K + , and lysis of red blood cells releases K + into the plasma, artificially elevating the plasma [K + ].

The large concentration difference of K + across cell membranes (approximately 146 mEq/L) is maintained by the Na + -K + -adenosine triphosphatase (ATPase). This K + gradient is important in maintaining the potential difference across cell membranes. Thus K + is critical for the excitability of nerve and muscle cells and for the contractility of cardiac, skeletal, and smooth muscle cells ( Fig. 7.1 ).

Fig. 7.1, The effects of variations in plasma K + concentration on the resting membrane potential of skeletal muscle. Hyperkalemia causes the membrane potential to become less negative and decreases the excitability by inactivating fast Na + channels, which are responsible for the depolarizing phase of the action potential. Hypokalemia hyperpolarizes the membrane potential and thereby reduces excitability, because a larger stimulus is required to depolarize the membrane potential to the threshold potential. Resting indicates the “normal” resting membrane potential. Normal threshold indicates the membrane threshold potential.

In the Clinic

Cardiac arrhythmias are produced by both hypokalemia and hyperkalemia. The electrocardiogram (ECG; Fig. 7.2 ) monitors the electrical activity of the heart and is a quick and easy way to determine whether changes in plasma [K + ] influence the heart and other excitable cells. In contrast, measurements of the plasma [K + ] by the clinical laboratory require a blood sample, and values often are not immediately available. The first sign of hyperkalemia is the appearance of tall, thin T waves on the ECG. Further increases in the plasma [K + ] prolong the PR interval, depress the ST segment, and lengthen the QRS interval on the ECG. Finally, as the plasma [K + ] approaches 10 mEq/L, the P wave disappears, the QRS interval broadens, the ECG appears as a sine wave, and the ventricles fibrillate (i.e., manifest rapid, uncoordinated contractions of muscle fibers). Hypokalemia prolongs the QT interval, inverts the T wave, and lowers the ST segment on the ECG.

Fig. 7.2, Electrocardiograms from individuals with varying plasma K + concentrations. See the text for details.

After a meal, the K + absorbed by the gastrointestinal tract enters the ECF within minutes ( Fig. 7.3 ). If the K + ingested during a normal meal (≈33 mEq) were to remain in the ECF compartment (14 L), the plasma [K + ] would increase by 2.4 mEq/L (33 mEq added to 14 L of ECF):


33 mEq / 14 L = 2.4 mEq / L

Fig. 7.3, Overview of potassium homeostasis. An increase in plasma insulin, epinephrine, or aldosterone stimulates K + movement into cells and decreases plasma K + concentration ([K + ]), whereas a decrease in the plasma concentration of these hormones has the opposite effect and increases plasma [K + ]. The amount of K + in the body is determined by the kidneys. An individual is in K + balance when dietary intake and urinary output (plus output by the gastrointestinal tract) are equal. The excretion of K + by the kidneys is regulated by plasma [K + ], aldosterone, and arginine vasopressin (AVP) .

This rise in the plasma [K + ], which could have deleterious effects on the electrical activity of the heart and other excitable tissues, is prevented by the rapid uptake (within minutes) of K + into cells. Because the excretion of K + by the kidneys after a meal is relatively slow (within hours), the uptake of K + by cells is essential to prevent life-threatening hyperkalemia. Maintaining total body K + constant requires all the K + absorbed by the gastrointestinal tract to eventually be excreted by the kidneys. This process requires about 6 hours.

Regulation of Plasma [K + ]

Several hormones, including epinephrine , insulin , and aldosterone , increase K + uptake into skeletal muscle, liver, bone, and red blood cells by stimulating Na + -K + -ATPase, the Na + -K + -2Cl symporter, and the Na + -Cl symporter in these cells ( Box 7.1 ; see Fig. 7.3 ). Acute stimulation of K + uptake (i.e., within minutes) is mediated by an increase in the activity of existing Na + -K + -ATPase, Na + -K + -2Cl , and Na + -Cl transporters, whereas the chronic increase in K + uptake (i.e., within hours to days) is mediated by an increase in the quantity of Na + -K + -ATPase. A rise in the plasma [K + ] that follows K + absorption by the gastrointestinal tract stimulates insulin secretion from the pancreas, aldosterone release from the adrenal cortex, and epinephrine secretion from the adrenal medulla. In contrast, a decrease in the plasma [K + ] inhibits the release of these hormones. Whereas insulin and epinephrine act within a few minutes, aldosterone requires about 1 hour to stimulate K + uptake into cells.

BOX 7.1
Major Factors, Hormones, and Drugs Influencing the Distribution of K + Between the Intracellular and Extracellular Fluid Compartments

Physiologic: Keep Plasma [K + ] Constant

  • Adrenergic receptor agonists

  • Insulin

  • Aldosterone

Pathophysiologic: Displace Plasma [K + ] From Normal

  • Acid-base disorders

  • Plasma osmolality

  • Cell lysis

  • Vigorous exercise

Drugs That Induce Hyperkalemia

  • Dietary potassium supplements

  • Angiotensin-converting enzyme inhibitors

  • K + -sparing diuretics (see Chapter 10 )

  • Heparin

Epinephrine

Catecholamines affect the distribution of K + across cell membranes by activating α- and β 2 -adrenergic receptors. The stimulation of α-adrenoceptors releases K + from cells, especially in the liver, whereas the stimulation of β 2 -adrenceptors promotes K + uptake by cells. For example, the activation of β 2 -adrenoceptors after exercise is important in preventing hyperkalemia. The rise in plasma [K + ] after a K + -rich meal is greater if the patient has been pretreated with propranolol, a β 2 -adrenoceptor antagonist. Furthermore, the release of epinephrine during stress (e.g., myocardial ischemia) can lower the plasma [K + ] rapidly.

Insulin

Insulin also stimulates K + uptake into cells. The importance of insulin is illustrated by two observations. First, the rise in plasma [K + ] after a K + -rich meal is greater in patients with diabetes mellitus (i.e., insulin deficiency) than in healthy people. Second, insulin (and glucose to prevent insulin-induced hypoglycemia) can be infused to correct hyperkalemia. Insulin is the most important hormone that shifts K + into cells after the ingestion of K + in a meal. Although insulin-stimulated glucose uptake into cells is impaired in patients with chronic kidney disease (CKD), insulin stimulation of K + uptake into cells is normal.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here